カテゴリー： IMARC, 世界, 医療/バイオ

不妊検査の世界市場2023-2028：産業動向、シェア、規模、成長、機会・予測

◆英語タイトル：Fertility Test Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
	◆商品コード：IMARC23FB0074 ◆発行会社（リサーチ会社）：IMARC ◆発行日：2023年2月1日 ◆ページ数：145 ◆レポート形式：英語 / PDF ◆納品方法：Eメール ◆調査対象地域：グローバル ◆産業分野：医療

◆販売価格オプション（消費税別）

Single User	USD2,999 ⇒換算￥449,850	見積依頼/購入/質問フォーム
Five User	USD3,999 ⇒換算￥599,850	見積依頼/購入/質問フォーム
Enterprisewide	USD4,999 ⇒換算￥749,850	見積依頼/購入/質問フォーム

★IMARCに受託調査の見積を依頼する

※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

IMARC社の本調査資料では、2022年に518.1百万ドルであった世界の不妊検査市場規模が、2028年までに768.9百万ドルに到達し、予測期間中に年平均6.6%で拡大すると予測しています。本資料は、不妊検査の世界市場を調査対象とし、序論、範囲・調査手法、エグゼクティブサマリー、イントロダクション、製品別（排卵予測キット、妊婦用監視装置、男性不妊検査製品）分析、購入形態別（OTC、処方箋）分析、用途別（女性不妊検査、男性不妊検査）分析、エンドユーザー別（病院、在宅医療、不妊治療クリニック、その他）分析、地域別（北米、アジア太平洋、ヨーロッパ、中南米、中東・アフリカ）分析、SWOT分析、バリューチェーン分析、ポーターズファイブフォース分析、価格分析、競争状況などをまとめています。本資料内には、Abbott Laboratories、AdvaCare Pharma、Ava AG、Babystart Ltd. (Snowden Healthcare)、Church & Dwight Co. Inc.、Fairhaven Health LLC、Geratherm Medical AG、Prestige Consumer Healthcare Inc.、Quidel Corporation、UEBE Medical GmbH、Valley Electronics AG and viO HealthTech Limited.などの企業情報が含まれています。
・序論
・範囲・調査手法
・エグゼクティブサマリー
・イントロダクション
・世界の不妊検査市場規模：製品別
- 排卵予測キットの市場規模
- 妊婦用監視装置の市場規模
- 男性不妊検査製品の市場規模
・世界の不妊検査市場規模：購入形態別
- OTCにおける市場規模
- 処方箋における市場規模
・世界の不妊検査市場規模：用途別
- 女性不妊検査における市場規模
- 男性不妊検査における市場規模
・世界の不妊検査市場規模：エンドユーザー別
- 病院における市場規模
- 在宅医療における市場規模
- 不妊治療クリニックにおける市場規模
- その他における市場規模
・世界の不妊検査市場規模：地域別
- 北米の不妊検査市場規模
- アジア太平洋の不妊検査市場規模
- ヨーロッパの不妊検査市場規模
- 中南米の不妊検査市場規模
- 中東・アフリカの不妊検査市場規模
・SWOT分析
・バリューチェーン分析
・ポーターズファイブフォース分析
・価格分析
・競争状況

The global fertility test market size reached US$ 518.1 Million in 2022. Looking forward, IMARC Group expects the market to reach US$ 768.9 Million by 2028, exhibiting a growth rate (CAGR) of 6.6% during 2023-2028.

Fertility tests are performed to diagnose problems that prevent couples from conceiving. They comprise blood tests, pelvic examination, semen analysis, basal body temperature (BBT) charting, post coital test, transvaginal (pelvic) ultrasound exam, hysterosalpingogram or HSG, hysteroscopy, and laparoscopy. They are reliable, valid, and assist in determining a suitable treatment. In addition, they prevent the spread of sexually transmitted infections (STIs) in the body. Fertility tests also help detect cervical cancer and abnormal cells around the cervix. As a result, they are carried out in hospitals, home care, and fertility clinics.

Fertility Test Market Trends:
The growing prevalence of diseases, such as polycystic ovary syndrome (PCOS), due to the overproduction of estrogen by the ovaries represents one of the key factors driving the market. Moreover, there is a rise in infertility rates across the globe due to lifestyle changes and increasing stress and obesity, which is caused by a lack of physical exercise and alterations in dietary pattern. This, along with the increasing awareness among the masses about the benefits of fertility tests, is propelling the growth of the market. In addition, the launch of technologically advanced products to treat infertility among the masses is positively influencing the market. Besides this, key market players are extensively investing in research and development (R&D) activities to introduce pregnancy and ovulation test kits for centralizing all fertility-related data. This, coupled with the burgeoning healthcare industry, is offering lucrative growth opportunities to industry investors. Apart from this, there is an increase in the demand for easy-to-use fertility monitors with high accuracy. The rising utilization of artificial intelligence (AI) in sperm analysis is expected to bolster the growth of the market.

Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global fertility test market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on product, mode of purchase, application and end user.

Breakup by Product:

Ovulation Prediction Kits
Fertility Monitors
Male Fertility Testing Products

Breakup by Mode of Purchase:

OTC-based
Prescription-based

Breakup by Application:

Female Fertility Testing
Male Fertility Testing

Breakup by End User:

Hospitals
Home Care Settings
Fertility Clinics
Others

Breakup by Region:

North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa

Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Abbott Laboratories, AdvaCare Pharma, Ava AG, Babystart Ltd. (Snowden Healthcare), Church & Dwight Co. Inc., Fairhaven Health LLC, Geratherm Medical AG, Prestige Consumer Healthcare Inc., Quidel Corporation, UEBE Medical GmbH, Valley Electronics AG and viO HealthTech Limited.

Key Questions Answered in This Report
1. What was the size of the global fertility test market in 2022?
2. What is the expected growth rate of the global fertility test market during 2023-2028?
3. What are the key factors driving the global fertility test market?
4. What has been the impact of COVID-19 on the global fertility test market?
5. What is the breakup of the global fertility test market based on the product?
6. What is the breakup of the global fertility test market based on the mode of purchase?
7. What is the breakup of the global fertility test market based on the application?
8. What is the breakup of the global fertility test market based on the end user?
9. What are the key regions in the global fertility test market?
10. Who are the key players/companies in the global fertility test market?

❖ レポートの目次 ❖

1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Fertility Test Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Product
6.1 Ovulation Prediction Kits
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Fertility Monitors
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 Male Fertility Testing Products
6.3.1 Market Trends
6.3.2 Market Forecast
7 Market Breakup by Mode of Purchase
7.1 OTC-based
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Prescription-based
7.2.1 Market Trends
7.2.2 Market Forecast
8 Market Breakup by Application
8.1 Female Fertility Testing
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Male Fertility Testing
8.2.1 Market Trends
8.2.2 Market Forecast
9 Market Breakup by End User
9.1 Hospitals
9.1.1 Market Trends
9.1.2 Market Forecast
9.2 Home Care Settings
9.2.1 Market Trends
9.2.2 Market Forecast
9.3 Fertility Clinics
9.3.1 Market Trends
9.3.2 Market Forecast
9.4 Others
9.4.1 Market Trends
9.4.2 Market Forecast
10 Market Breakup by Region
10.1 North America
10.1.1 United States
10.1.1.1 Market Trends
10.1.1.2 Market Forecast
10.1.2 Canada
10.1.2.1 Market Trends
10.1.2.2 Market Forecast
10.2 Asia-Pacific
10.2.1 China
10.2.1.1 Market Trends
10.2.1.2 Market Forecast
10.2.2 Japan
10.2.2.1 Market Trends
10.2.2.2 Market Forecast
10.2.3 India
10.2.3.1 Market Trends
10.2.3.2 Market Forecast
10.2.4 South Korea
10.2.4.1 Market Trends
10.2.4.2 Market Forecast
10.2.5 Australia
10.2.5.1 Market Trends
10.2.5.2 Market Forecast
10.2.6 Indonesia
10.2.6.1 Market Trends
10.2.6.2 Market Forecast
10.2.7 Others
10.2.7.1 Market Trends
10.2.7.2 Market Forecast
10.3 Europe
10.3.1 Germany
10.3.1.1 Market Trends
10.3.1.2 Market Forecast
10.3.2 France
10.3.2.1 Market Trends
10.3.2.2 Market Forecast
10.3.3 United Kingdom
10.3.3.1 Market Trends
10.3.3.2 Market Forecast
10.3.4 Italy
10.3.4.1 Market Trends
10.3.4.2 Market Forecast
10.3.5 Spain
10.3.5.1 Market Trends
10.3.5.2 Market Forecast
10.3.6 Russia
10.3.6.1 Market Trends
10.3.6.2 Market Forecast
10.3.7 Others
10.3.7.1 Market Trends
10.3.7.2 Market Forecast
10.4 Latin America
10.4.1 Brazil
10.4.1.1 Market Trends
10.4.1.2 Market Forecast
10.4.2 Mexico
10.4.2.1 Market Trends
10.4.2.2 Market Forecast
10.4.3 Others
10.4.3.1 Market Trends
10.4.3.2 Market Forecast
10.5 Middle East and Africa
10.5.1 Market Trends
10.5.2 Market Breakup by Country
10.5.3 Market Forecast
11 SWOT Analysis
11.1 Overview
11.2 Strengths
11.3 Weaknesses
11.4 Opportunities
11.5 Threats
12 Value Chain Analysis
13 Porters Five Forces Analysis
13.1 Overview
13.2 Bargaining Power of Buyers
13.3 Bargaining Power of Suppliers
13.4 Degree of Competition
13.5 Threat of New Entrants
13.6 Threat of Substitutes
14 Price Analysis
15 Competitive Landscape
15.1 Market Structure
15.2 Key Players
15.3 Profiles of Key Players
15.3.1 Abbott Laboratories
15.3.1.1 Company Overview
15.3.1.2 Product Portfolio
15.3.1.3 Financials
15.3.1.4 SWOT Analysis
15.3.2 AdvaCare Pharma
15.3.2.1 Company Overview
15.3.2.2 Product Portfolio
15.3.3 Ava AG
15.3.3.1 Company Overview
15.3.3.2 Product Portfolio
15.3.4 Babystart Ltd. (Snowden Healthcare)
15.3.4.1 Company Overview
15.3.4.2 Product Portfolio
15.3.5 Church & Dwight Co. Inc.
15.3.5.1 Company Overview
15.3.5.2 Product Portfolio
15.3.5.3 Financials
15.3.5.4 SWOT Analysis
15.3.6 Fairhaven Health LLC
15.3.6.1 Company Overview
15.3.6.2 Product Portfolio
15.3.7 Geratherm Medical AG
15.3.7.1 Company Overview
15.3.7.2 Product Portfolio
15.3.7.3 Financials
15.3.8 Prestige Consumer Healthcare Inc.
15.3.8.1 Company Overview
15.3.8.2 Product Portfolio
15.3.8.3 Financials
15.3.8.4 SWOT Analysis
15.3.9 Quidel Corporation
15.3.9.1 Company Overview
15.3.9.2 Product Portfolio
15.3.9.3 Financials
15.3.9.4 SWOT Analysis
15.3.10 UEBE Medical GmbH
15.3.10.1 Company Overview
15.3.10.2 Product Portfolio
15.3.11 Valley Electronics AG
15.3.11.1 Company Overview
15.3.11.2 Product Portfolio
15.3.12 viO HealthTech Limited
15.3.12.1 Company Overview
15.3.12.2 Product Portfolio

❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 不妊検査の世界市場2023-2028：産業動向、シェア、規模、成長、機会・予測(Fertility Test Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028)]についてメールでお問い合わせはこちらでお願いします。

GlobalResearch.jp

不妊検査の世界市場2023-2028：産業動向、シェア、規模、成長、機会・予測

グローバル市場調査/マーケットリサーチ会社：レポート販売と委託調査サービス提供 www.GlobalResearch.jp